New Key Statistics Module, Z-Score and F-Score
OTCPK:JWCTF Key Ratios
Market Cap $ M | 151.28 |
Enterprise Value $ M | 41.33 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.60 |
Price/Sales | 6.00 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 23.00 |
EPS (TTM) $ | -0.26 |
Beneish M-Score | -3.78 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -6.70 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.37 |
EV-to-EBITDA | -0.38 |
PEG | -- |
Shares Outstanding M | 414.36 |
Net Margin (%) | -476.65 |
Operating Margin % | -397.09 |
Pre-tax Margin (%) | -476.65 |
Quick Ratio | 3.90 |
Current Ratio | 4.04 |
ROA % (ttm) | -31.62 |
ROE % (ttm) | -38.83 |
ROIC % (ttm) | -46.06 |
Dividend Yield % | -- |
Altman Z-Score | -2.68 |
JWCTF Number of Guru Trades
JWCTF Volume of Guru Trades
Gurus Latest Trades with OTCPK:JWCTF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:JWCTF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
JW (Cayman) Therapeutics Co Ltd Insider Transactions
No Available Data
News about OTCPK:JWCTF
Total 0- 1